Dr Teresa Sadras is Head of the Leukaemia Biology and Functional Genomics Laboratory at the Olivia Newton-John Cancer Research Institute (ONJCRI) and an internationally recognised translational researcher in haematological malignancies. She leads a research program focused on the molecular mechanisms driving paediatric and adult acute lymphoblastic leukaemia and other lymphoid cancers, with an emphasis on functional genomics, disease modelling, and drug profiling to identify new therapeutic vulnerabilities.
Dr Sadras has a strong track record in national and international collaborative research, having previously held senior positions at the Peter MacCallum Cancer Centre and conducted postdoctoral research in the USA. She has co-authored over 24 peer-reviewed publications in leading journals, delivered invited talks at more than 35 conferences, and contributed to multiple international consortia advancing translational haematology research.
Beyond her research, Dr Sadras is actively engaged in education and mentoring, supervising PhD, Masters, and Honours students across the University of Melbourne, La Trobe University, and the University of Adelaide, and serving as a tutor in the VCCC Master of Cancer Sciences program. She is also committed to fostering cross-institutional collaboration, clinician-scientist integration, and consumer engagement to accelerate research translation into improved patient care.
Dr Sadras holds honorary appointments at the Peter MacCallum Cancer Centre, La Trobe University, and the University of Melbourne, and serves on national and international scientific committees, including the New Directions in Leukemia Research and the Translational Precision Immuno-Oncology Council at ONJCRI.
